Novel glyproline GZK-111 with neuropsychotropic activity
Thе article represents a review of our own researches, which describes the design, synthesis and pharmacological properties of linear substituted glyproline GZK-111, a potential drug for the complex treatment of psychiatric pathologies, including anxiety, depressive disorders, and cognitive impairme...
Saved in:
Main Authors: | K. N. Koliasnikova (Author), A. G. Alyaeva (Author), E. A. Kuznetsova (Author) |
---|---|
Format: | Book |
Published: |
LLC "Publisher OKI",
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative study of pharmacokinetics and enzymatic resistance of the neuroprotective mean GZK-111 and noopept in rats
by: S. S. Boyko, et al.
Published: (2022) -
The <i>in vitro</i> neuroprotective activity of analogues of N-terminus substituted glyprolines
by: S. V. Nikolaev, et al.
Published: (2020) -
Neuroprotective properties of novel substituted glyprolines in vitro
by: T. A. Antipova, et al.
Published: (2019) -
HPLC-MS method development and validation for simultaneous quantitation of GZK-111 and CPG compounds in rat plasma
by: A. L. Podolko, et al.
Published: (2020) -
GLYPROLINES AS MODULATORS OF IMMUNOREACTIVITY WITHIN CONDITIONS OF "SOCIAL" STRESS
by: M. A. Samotrueva, et al.
Published: (2019)